Blog

Can High HDL Cholesterol Worsen Glaucoma Risk? Glaucoma is a leading cause of irreversible blindness worldwide, affecting millions of people. While high intraocular pressure (IOP) is a well-known risk factor, emerging research suggests that cholesterol levels—particularly high-density lipoprotein (HDL) cholesterol—may also play a role. But could high HDL cholesterol actually worsen glaucoma risk? Let’s explore […]

Preventable Glaucoma Vision Loss Hindered by Treatment Costs Glaucoma is a leading cause of irreversible blindness worldwide, affecting millions of people. Yet, what makes this condition even more tragic is that much of the vision loss it causes is preventable with timely diagnosis and treatment. Unfortunately, the high cost of glaucoma care creates significant barriers

National Reconstruction Fund Invests $27M in Glaucoma Treatment Innovation The National Reconstruction Fund (NRF) has announced a groundbreaking investment of $27 million into cutting-edge glaucoma treatment innovation. This significant funding aims to accelerate research, development, and commercialization of advanced therapies to combat glaucoma—a leading cause of irreversible blindness worldwide. The move underscores the government’s commitment

Understanding Age-Related Glaucoma Progression: Key Insights Glaucoma is a leading cause of irreversible blindness worldwide, particularly affecting older adults. As we age, the risk of developing glaucoma increases, making it crucial to understand how this condition progresses over time. Early detection and proper management can help preserve vision and improve quality of life. In this

Can Good Cholesterol Harm Your Glaucoma Risk? For years, high-density lipoprotein (HDL), often referred to as “good cholesterol,” has been celebrated for its role in heart health. It helps remove low-density lipoprotein (LDL), or “bad cholesterol,” from the bloodstream, reducing the risk of cardiovascular disease. But could there be a downside to having high HDL

PreserFlo MicroShunt Complications Lead to Corneal Damage and Surgical Revision The PreserFlo MicroShunt has been widely adopted as a minimally invasive surgical option for glaucoma patients, offering an alternative to traditional trabeculectomy. While the device has shown promise in reducing intraocular pressure (IOP), emerging reports highlight complications such as corneal damage and the need for

Optic Nerve Hemoglobin Levels Impact Glaucoma Structure and Function Glaucoma is a leading cause of irreversible blindness worldwide, characterized by progressive damage to the optic nerve and retinal ganglion cells. While elevated intraocular pressure (IOP) has long been recognized as a major risk factor, emerging research suggests that optic nerve hemoglobin levels may play a